NCT05561374 2024-11-29Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade GliomaOblato, Inc.Phase 1 Active not recruiting16 enrolled
NCT00509821 2019-04-05Enzastaurin Before and Concomitant With Radiation, Followed by Enzastaurin in Participants With Newly Diagnosed GlioblastomaEli Lilly and CompanyPhase 2 Completed60 enrolled 11 charts